Alpha Teknova, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02080L1026
USD
2.79
-0.09 (-3.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Kronos Bio, Inc.
FibroGen, Inc.
Alpha Teknova, Inc.
Ocuphire Pharma, Inc.
SCYNEXIS, Inc.
CytomX Therapeutics, Inc.
Capricor Therapeutics, Inc.
aTyr Pharma, Inc.
Annovis Bio, Inc.
Werewolf Therapeutics, Inc.
Anebulo Pharmaceuticals, Inc.

Why is Alpha Teknova, Inc. ?

1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate -239.64% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -17.29
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -50.36%, its profits have risen by 35.4%
3
Below par performance in long term as well as near term
  • Along with generating -50.36% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alpha Teknova, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Alpha Teknova, Inc.
-50.36%
0.77
76.07%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
10.34%
EBIT Growth (5y)
-239.64%
EBIT to Interest (avg)
-17.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.38
Tax Ratio
0.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
21.14%
ROCE (avg)
1.15%
ROE (avg)
0.76%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.22
EV to EBIT
-8.57
EV to EBITDA
-13.30
EV to Capital Employed
2.35
EV to Sales
3.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.48%
ROE (Latest)
-25.08%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -9.22 MM

NET PROFIT(HY)

Higher at USD -7.86 MM

ROCE(HY)

Highest at -22.79%

RAW MATERIAL COST(Y)

Fallen by -979.74% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 3.92 times

DEBTORS TURNOVER RATIO(HY)

Highest at 8.17 times

NET SALES(Q)

Highest at USD 10.45 MM

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS

Here's what is working for Alpha Teknova, Inc.

Operating Cash Flow
Highest at USD -9.22 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit
Higher at USD -7.86 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales
Highest at USD 10.45 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Inventory Turnover Ratio
Highest at 3.92 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 8.17 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -979.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales